Last C$3.11 CAD
Change Today +0.16 / 5.42%
Volume 1.1K
TLB On Other Exchanges
Symbol
Exchange
Toronto
NASDAQ CM
Frankfurt
As of 3:59 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

tearlab corp (TLB) Snapshot

Open
C$2.89
Previous Close
C$2.95
Day High
C$3.11
Day Low
C$2.89
52 Week High
01/6/14 - C$10.95
52 Week Low
11/6/14 - C$2.50
Market Cap
104.5M
Average Volume 10 Days
718.5
EPS TTM
C$-0.63
Shares Outstanding
33.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TEARLAB CORP (TLB)

Related News

No related news articles were found.

tearlab corp (TLB) Related Businessweek News

No Related Businessweek News Found

tearlab corp (TLB) Details

TearLab Corp. operates as an ophthalmic device company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.

101 Employees
Last Reported Date: 03/17/14
Founded in 1996

tearlab corp (TLB) Top Compensated Officers

Chairman, Chief Executive Officer and Secreta...
Total Annual Compensation: $347.2K
President and Chief Operating Officer
Total Annual Compensation: $74.5K
Chief Financial Officer and Treasurer
Total Annual Compensation: $172.3K
Vice President of Operations
Total Annual Compensation: $353.7K
Vice President of Regulatory
Total Annual Compensation: $180.0K
Compensation as of Fiscal Year 2013.

tearlab corp (TLB) Key Developments

TearLab Corporation Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 02:30 PM

TearLab Corporation Presents at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum, Nov-20-2014 02:30 PM. Venue: The Westin Grand Central, New York, New York, United States.

Tearlab Corporation Reports Consolidated Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

TearLab Corporation reported consolidated unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of $5,212,000 compared with $4,207,000 for the same period last year. Loss from operations was $6,114,000 compared with $3,829,000 for the same period last year. Net loss and comprehensive loss was $5,785,000 or $0.18 basic and diluted per share compared with $4,240,000 or $0.13 basic and diluted per share for the same period last year. For the nine months, the company reported revenue of $14,422,000 compared with $10,207,000 for the same period last year. Loss from operations was $17,920,000 compared with $12,269,000 for the same period last year. Net loss and comprehensive loss was $16,782,000 or $0.53 basic and diluted per share compared with $24,837,000 or $0.83 basic and diluted per share for the same period last year.

TearLab Corporation Presents at Stephens Inc. Fall Investment Conference 2014, Nov-12-2014 02:00 PM

TearLab Corporation Presents at Stephens Inc. Fall Investment Conference 2014, Nov-12-2014 02:00 PM. Venue: New York Palace Hotel, 455 Madison Avenue, New York, New York, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TLB:CN C$3.11 CAD +0.16

TLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TLB.
View Industry Companies
 

Industry Analysis

TLB

Industry Average

Valuation TLB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.9x
Price/Book 3.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEARLAB CORP, please visit www.tearlab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.